Replies to post #141679 on Biotech Values

[DewDiligence]

As far as I know, PFE’s Rituxan FoB was developed in-house (i.e. by the biologics group formerly at Wyeth). I first mentioned this program in #msg-72865371.

[DewDiligence]

PFE begins phase-1 study of Herceptin FoB:

http://clinicaltrials.gov/ct2/show/NCT01603264?term=NCT01603264

This makes two big-selling drugs for which PFE is known to be working on an in-house FoB: Herceptin and Rituxan (#msg-72865371).

(Thanks to Duncan Emerton, a/k/a Biosimilarz, for the Herceptin FoB find.)